Davis Polk advised the underwriters in connection with an initial public offering of 9,315,000 shares of common stock of Berkeley Lights, Inc. at $22.00 per share (which includes the exercise in full by the underwriters of their option to purchase up to 1,215,000 additional shares), for total gross proceeds of $204.9 million. The common stock is listed on the Nasdaq Global Select Market under the symbol “BLI.”
Based in Emeryville, California, Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth LeBow, Jonathan Bye and Ganiatu Afolabi. The intellectual property and technology transactions team included partner Frank J. Azzopardi and associates Jesse L. Hallock and Daniel P. Kearney. The tax team included associate Daniel L. Jose. Counsel Marcie A. Goldstein provided FINRA advice. Associate Matthew R. Silver provided 1940 Act advice. Members of the Davis Polk team are based in the Northern California and New York offices.